rac threo-dihydro bupropion
CAS : 92264-82-9
Ref. 3D-FR27577
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté |
Informations sur le produit
- (a-R)-rel-3-chloro-a-[(1R)-1-[(1,1-dimethylethyl)amino]ethyl]benzenemethanolrac threo-hydroxybupropion
- (1S,2S)-2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-ol
- Benzenemethanol, 3-chloro-α-[(1R)-1-[(1,1-dimethylethyl)amino]ethyl]-, (αR)-rel-
- Benzenemethanol, 3-chloro-α-[1-[(1,1-dimethylethyl)amino]ethyl]-, (R*,R*)-
- Threohydroxybupropion
- rel-(αR)-3-Chloro-α-[(1R)-1-[(1,1-dimethylethyl)amino]ethyl]benzenemethanol
Rac threo-dihydro bupropion is an enzyme inhibitor that blocks the activity of the enzymes monoamine oxidase type A and B. Rac threo-dihydro bupropion inhibits the metabolic breakdown of neurotransmitters such as dopamine, serotonin, and norepinephrine which are produced by neurons in the central nervous system. It is used as a treatment for major depressive disorder, seasonal affective disorder, and bipolar depression. Rac threo-dihydro bupropion has also been shown to be effective in reducing weight gain in humans who have a body mass index greater than 25. The compound does not inhibit the activity of other human enzymes such as cytochrome P450 or CYP2D6. Rac threo-dihydro bupropion binds to 5-HT2 receptors on cells in the brain which produce serotonin.
